GlycA: a new biomarker for systemic inflammation and cardiovascular disease (CVD) risk assessment is a research paper published in Journal of Laboratory and Precision Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 89 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural NIH HHS
Grant: ZIA HL006092
National Institutes of Health
Grant: 1ZIAHL006092-11
Development of recombinant Lecithin Cholesterol Acyltransferase as a therapeutic
FWCI
7.27
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals